Unicycive Therapeutics, Inc.
UNCY
$4.23
-$0.02-0.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.94% | -24.38% | -19.18% | -22.58% | -14.61% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.42% | 60.56% | -17.85% | 180.18% | -25.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -38.60% | 45.69% | 36.68% | 15.66% | 18.09% |
| Total Current Assets | 7.97% | -11.64% | -18.00% | -14.33% | -14.75% |
|
|
|||||
| Total Current Assets | 7.97% | -11.64% | -18.00% | -14.33% | -14.75% |
| Net Property, Plant & Equipment | -21.96% | -16.53% | -13.57% | 28.75% | -8.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 7.33% | -11.75% | -17.90% | -13.71% | -14.67% |
|
|
|||||
| Total Accounts Payable | -44.52% | 32.04% | 93.07% | -62.77% | 18.71% |
| Total Accrued Expenses | -47.67% | 16.31% | 19.05% | -4.16% | -12.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.36% | -2.84% | 4.06% | 50.56% | 4.96% |
| Total Finance Division Other Current Liabilities | -3.53% | -44.09% | 196.94% | -21.58% | -67.66% |
| Total Other Current Liabilities | -3.53% | -44.09% | 196.94% | -21.58% | -67.66% |
| Total Current Liabilities | -18.65% | -30.86% | 130.61% | -20.07% | -56.79% |
|
|
|||||
| Total Current Liabilities | -18.65% | -30.86% | 130.61% | -20.07% | -56.79% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -55.85% | -3.28% | -26.34% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -18.65% | -31.20% | 126.01% | -19.73% | -56.42% |
|
|
|||||
| Common Stock & APIC | 10.36% | 3.01% | 1.03% | 76.96% | -0.40% |
| Retained Earnings | -6.40% | 0.56% | -26.99% | -5.41% | 11.53% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 45.76% | 51.68% | -73.32% | 287.59% | 39.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | 45.76% | 51.68% | -73.32% | 287.59% | 39.30% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.76% | 51.68% | -73.32% | -11.14% | 44.22% |
|
|
|||||